The pharmaceutical industry’s response to the novel coronavirus may not rescue its ailing reputation. But it will, apparently, be televised — and the footage could nudge the public’s perception of how the drug business works.

That, at least, is the thinking behind a 30-minute weekly show from the multinational drug company Johnson & Johnson being launched Tuesday. The eight-episode series, which will be broadcast live online, will focus on the company’s efforts to find a vaccine for the virus that causes Covid-19. J&J hired journalist Lisa Ling, of CNN’s “This Is Life,” to host the program.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy